Transcatheter innovations in tricuspid regurgitation: Cardioband

Antonio Mangieri; Azeem Latib

doi:10.1016/j.pcad.2019.10.002

Transcatheter innovations in tricuspid regurgitation: Cardioband

Prog Cardiovasc Dis. 2019 Nov-Dec;62(6):482-485. doi: 10.1016/j.pcad.2019.10.002. Epub 2019 Oct 25.

Authors

Antonio Mangieri¹, Azeem Latib²

Affiliations

¹ GVM Care and Research, Maria Cecilia Hospital, Cotignola, Italy.
² Division of Cardiology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY. Electronic address: alatib@gmail.com.

PMID: 31669500
DOI: 10.1016/j.pcad.2019.10.002

Abstract

Functional tricuspid regurgitation (FTR) has been neglected for a long time, however its prevalence and clinical relevance is not negligible. In presence of FTR, a certain quote of annular dilatation is present thus contributing to the mechanism of regurgitation. Historically, surgical annuloplasty has been the main treatment to correct FTR; however surgical repair is limited by a high risk of mortality and morbidity. For this reason, percutaneous tricuspid annuloplasty is an attractive tool for the treatment of FTR in patients at high surgical risk. A number of both direct and indirect percutaneous annuloplasty systems are currently under pre-clinical and clinical development. This review will discuss the Cardioband system, a novel direct annuloplasty device with promising result in terms of clinical safety and efficacy.

Keywords: Functional tricuspid regurgitation; Percutaneous tricuspid annuloplasty; Tricuspid regurgitation.

Publication types

Review

MeSH terms

Cardiac Catheterization / methods
Cardiac Valve Annuloplasty* / adverse effects
Cardiac Valve Annuloplasty* / instrumentation
Cardiac Valve Annuloplasty* / methods
Equipment Design
Heart Valve Prosthesis*
Humans
Risk Adjustment / methods
Severity of Illness Index
Tricuspid Valve Insufficiency* / diagnosis
Tricuspid Valve Insufficiency* / surgery